( tion the relevance of laboratory based ...)The very defensive caterpillar

(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod

(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h

(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha

...e isolated a new peptide antibiotic from the Ameri... many diseases in oysters. , The new antimicrobial...ect against bacteria in Crassostrea virginica, a s...ant economically to Atlantic and Gulf Coast fisher...disease-resistant oysters for aquaculture and fish...

...e Department of Energy,s Lawrence Berkeley Nationa...ct tens of thousands of high-quality images of bio...y and automatically, with accuracy approaching tha...thm, described as "particle picking by segmentatio...er of methods for determining biological structure...

...c. 4 as an advance online publication of the journ...have virtually no activity in a key part of the br...erving emotions. , Mirror neurons fire when a pers... she observes the same action performed by others....n matching system provides a neural mechanism by w...

(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel

(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced

(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,

(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou

...d., Nov. 4 PharmAthene, Inc.,(NYSE Alternext US: ...ermeasures against biological and chemical threats...and Chief Executive Officer of PharmAthene,will pr...care Conference in,New York on Wednesday, November...s II Room (4th Floor) at The New York Palace Hotel...

...celand, November 4 deCODE,genetics (Nasdaq: DCGN ...aring before a Nasdaq Listing Qualifications Panel...asdaq Marketplace Rule 4450(b)(1)(A), which,requir...$50 million. On,October 31, 2008, deCODE received ... Market LLC indicating that the Company had not re...

...d., Nov. 4 Novavax, Inc. (Nasdaq:,NVAX) today ann...financial,results in a press release to be issued ... The Company will hold an investor conference call...stern Time on November 10,2008. The call will be h...icer Dr. Rahul Singhvi and other members of senior...

Human Serum (All Male Donors) from Irvine Scientific

Human Serum Type AB from Irvine Scientific

Senescence Colorimetric Assay Kit from BioVision

Rabbit Anti-Human TARDBP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.